455
Views
81
CrossRef citations to date
0
Altmetric
Articles

Auger processes in the 21st century

, PhD
Pages 959-975 | Received 15 Jan 2008, Accepted 22 Jun 2008, Published online: 03 Jul 2009

References

  • Adam J F, Joubert A, Biston M C, Charvet A M, Peoc'h M, Le Bas J F, Balosso J, Esteve F, Elleaume H. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. International Journal of Radiation Oncology Biology Physics 2006; 64: 603–11
  • Adelstein S J. Biophysical apsects of Auger processes: A review of the literature 1987–1991. R W Howell, V R Narra, K SR Sastry, D V Rao. American Institute of Physics, Woodbury, NY 1992; 1–13, (http://www.aapm.org/pubs/books/PROC_8.pdf)
  • Auger P. Sur les rayons β secondaires produit dans un gaz par des rayons X. Comptes Rendues Hehdomadaires des Seances de L'Academie des Sciences 1925; 180: 65–68
  • Azure M T, Sastry K SR, Archer R D, Howell R W, Rao D V. Microscale synthesis of carboplatin labeled with the Auger emitter Pt-193m: Radiotoxicity versus chemotoxicity of the antitumor drug in mammalian cells. R W Howell, V R Narra, K SR Sastry, D V Rao. American Institute of Physics, Woodbury, NY 1992; 336–351, (http://www.aapm.org/pubs/books/default.asp)
  • Balagurumoorthy P, Chen K, Bash R C, Adelstein S J, Kassis A I. Mechanisms underlying production of double-strand breaks in plasmid DNA after decay of 125I-Hoechst. Radiation Research 2006; 166: 333–344
  • Bapat K, Chintalwar G J, Pandey U, Thakur V S, Sarma H D, Samuel G, Pillai M R, Chattopadhyay S, Venkatesh M. Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Applied Radiation and Isotopes 2005; 62: 389–393
  • Barth S, Joshi S, Marburger S, Ulrich V, Lindblad A, Ohrwall G, Bjorneholm O, Hergenhahn U. Observation of resonant interatomic coulombic decay in Ne clusters. Journal of Chemical Physics 2005; 122: 241102
  • K F Baverstock, Charton, D E. DNA damage by Auger emitters. London, Taylor & Francis. 1988
  • Baverstock K F, Cundall R B. Solitons and energy transfer in DNA. Nature 1988; 332: 312–313
  • Bé M M, Chiste V, Dulieu C. Detailed calculation of K- and L-Auger electron emission intensities following radioactive disintegration. Applied Radiation and Isotopes 2006; 64: 1435–1439
  • Biston M C, Joubert A, Adam J F, Elleaume H, Bohic S, Charvet A M, Esteve F, Foray N, Balosso J. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Research 2004; 64: 2317–2323
  • Boswell C A, Brechbiel M W. Auger electrons: Lethal, low energy, and coming soon to a tumor cell nucleus near you. Journal of Nuclear Medicine 2005; 46: 1946–1947
  • Boyd M, Ross S C, Dorrens J, Fullerton N E, Tan K W, Zalutsky M R, Mairs R J. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. Journal of Nuclear Medicine 2006; 47: 1007–1015
  • Bradley E W, Chan P C, Adelstein S J. The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiation Research 1975; 64: 555–563
  • Buchegger F, Adamer F, Schaffland A O, Kosinski M, Grannavel C, Dupertuis Y M, de Tribolet N, Mach J P, Delaloye A B. Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts. International Journal of Cancer 2004; 110: 145–149
  • Buchegger F, Perillo-Adamer F, Dupertuis Y M, Delaloye A B. Auger radiation targeted into DNA: A therapy perspective. European Journal of Nuclear Medicine Molecular Imaging 2006; 33: 1352–1363
  • Capello A, Krenning E, Bernard B, Reubi J C, Breeman W, de Jong M. 111In-labelled somatostatin analogues in a rat tumour model: Somatostatin receptor status and effects of peptide receptor radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging 2005; 32: 1288–1295
  • Carles A G, Malonda A G. Combined electron emission effects on the biologically damaging efficiency of 125I. International Journal of Radiation Biology 2006; 82: 211–220
  • Cederbaum L S, Zobeley J, Tarantelli F. Giant intermolecular decay and fragmentation of clusters. Physical Review Letters 1997; 79: 4778
  • Charlton D E, Booz J. A Monte Carlo treatment of the decay of I-125. Radiation Research 1981; 87: 10–23
  • Chen K, Wang K, Kirichian A M, Al Aowad A F, Iyer L K, Adelstein S J, Kassis A I. In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy. Molecular Cancer Therapeutics 2006a; 5: 3001–3013
  • Chen P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J, Minden M, Reilly R M. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. Journal of Nuclear Medicine 2006b; 47: 827–836
  • Corde S, Joubert A, Adam J F, Charvet A M, Le Bas J F, Esteve F, Elleaume H, Balosso J. Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. British Journal of Cancer 2004; 91: 544–551
  • Cornelissen B, Hu M, McLarty K, Costantini D, Reilly R M. Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells. Nuclear Medicine and Biology 2007; 34: 37–46
  • Datta K, Jaruga P, Dizdaroglu M, Neumann R D, Winters T A. Molecular analysis of base damage clustering associated with a site-specific radiation-induced DNA double-strand break. Radiation Research 2006; 166: 767–781
  • Datta K, Neumann R D, Winters T A. Characterization of complex apurinic/apyrimidinic-site clustering associated with an authentic site-specific radiation-induced DNA double-strand break. Proceedings of the National Academy of Sciences of the USA 2005a; 102: 10569–10574
  • Datta K, Neumann R D, Winters T A. Characterization of a complex 125I-induced DNA double-strand break: Implications for repair. International Journal of Radiation Biology 2005b; 81: 13–21
  • De Jong M, Valkema R, Van Gameren A, Van Boven H, Bex A, Van De Weyer E P, Burggraaf J D, Korner M, Reubi J C, Krenning E P. Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide. Journal of Nuclear Medicine 2004; 45: 1168–1171
  • Dingli D, Peng K W, Harvey M E, Vongpunsawad S, Bergert E R, Kyle R A, Cattaneo R, Morris J C, Russell S J. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochemical Biophysical Research Communications 2005; 337: 22–29
  • Edel S, Terrissol M, Peudon A, Kummerle E, Pomplun E. Computer simulation of strand break yields in plasmid pBR322: DNA damage following 125I decay. Radiation Protection Dosimetry 2006; 122: 136–140
  • Elmroth K, Stenerlow B. DNA-incorporated 125I induces more than one double-strand break per decay in mammalian cells. Radiation Research 2005; 163: 369–373
  • Emfietzoglou D, Nikjoo H. The effect of model approximations on single-collision distributions of low-energy electrons in liquid water. Radiation Research 2005; 163: 98–111
  • Emfietzoglou D, Nikjoo H. Accurate electron inelastic cross sections and stopping powers for liquid water over the 0.1–10 keV range based on an improved dielectric description of the Bethe surface. Radiation Research 2007; 167: 110–120
  • Ertl H H, Feinendegen L E, Heiniger H J. Iodine-125, a tracer in cell biology: Physical properties and biological aspects. Physics of Medicine and Biology 1970; 15: 447–456
  • Fairchild R G, Bond V P. Photon activation therapy. Strahlentherapie 1984; 160: 758–763
  • Fairchild R G, Brill A B, Ettinger K V. Radiation enhancement with iodinated deoxyuridine. Investigative Radiology 1982; 17: 407–416
  • Feinendegen L E. Biological damage from the Auger effect, possible benefits. Radiation Environmental Biophysics 1975; 12: 85–99
  • Feyer V, Bolognesi P, Coreno M, Prince K C, Avaldi L, Storchi L, Tarantelli F. Effects of nuclear dynamics in the low-kinetic-energy Auger spectra of CO and CO2. Journal of Chemical Physics 2005; 123: 224306
  • Foulon C F, Zhang Y Z, Adelstein S J, Kassis A I. Instantaneous preparation of radiolabeled 5-iodo-2'-deoxyuridine. Applied Radiation and Isotopes 1995; 46: 1039–1046
  • Fujii K, Akamatsu K, Yokoya A. Ion desorption from DNA components irradiated with 0.5 keV ultrasoft X-ray photons. Radiation Research 2004; 161: 435–441
  • Garnuszek P. Marked survival prolongation of mice bearing a transplantable colon adenocarcinoma by treatment with radioactive platinum-[125I]histamine complex. Preliminary report. Nuclear Medicine Review. Central and Eastern Europe 2004; 7: 113–116
  • Ghirmai S, Mume E, Tolmachev V, Sjoberg S. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives. Carbohydrate Research 2005; 340: 15–24
  • Ginj M, Chen J, Walter M A, Eltschinger V, Reubi J C, Maecke H R. Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. Clinical Cancer Research 2005a; 11: 1136–1145
  • Ginj M, Hinni K, Tschumi S, Schulz S, Maecke H R. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using Auger electron emitters. Journal of Nuclear Medicine 2005b; 46: 2097–2103
  • Goddu S M, Howell R W, Bouchet L G, Bolch W E, Rao D V. MIRD Cellular S values: Self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Society of Nuclear Medicine, Reston, VA 1997
  • Gupta S M, Herrera N, Spencer R P, Hosain F, Crucitti T W. Testicular-scrotal content of 201Tl and 67Ga after intravenous administration. International Journal of Nuclear Medicine and Biology 1981; 8: 211–212
  • Haefliger P, Agorastos N, Renard A, Giambonini-Brugnoli G, Marty C, Alberto R. Cell uptake and radiotoxicity studies of an nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]+. Bioconjugate Chemistry 2005; 16: 582–587
  • Häfliger P, Agorastos N, Spingler B, Georgiev O, Viola G, Alberto R. Induction of DNA-double-strand breaks by auger electrons from 99mTc complexes with DNA-binding ligands. ChemBioChem 2005; 6: 414–421
  • He Y, Das B, Baruchel S, Kumar P, Wiebe L, Reilly R M. Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage. Nuclear Medicine Communications 2004a; 25: 1125–1130
  • He Y, Neumann R D, Panyutin I G. Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing. Nucleic Acids Research 2004b; 32: 5359–5367
  • He Y, Panyutin I G, Karavanov A, Demidov V V, Neumann R D. Sequence-specific DNA strand cleavage by 111In-labeled peptide nucleic acids. European Journal of Nuclear Medicine and Molecular Imaging 2004c; 31: 837–845
  • Hikosaka Y, Aoto T, Lablanquie P, Penent F, Shigemasa E, Ito K. Experimental investigation of core-valence double photoionization. Physical Review Letters 2006; 97, 053003
  • Hikosaka Y, Lablanquie P, Penent F, Kaneyasu T, Shigemasa E, Eland J H, Aoto T, Ito K. Double photoionization into double core-hole states in Xe. Physical Review Letters 2007; 98: 183002
  • Hilgers K, Sudar S, Qaim S M. Experimental study and nuclear model calculations on the 192Os(p,n)192Ir reaction: Comparison of reactor and cyclotron production of the therapeutic radionuclide 192Ir. Applied Radiation and Isotopes 2005; 63: 93–98
  • Hofer K G. Closing address: Biophysical aspects of Auger processes. R W Howell, V R Narra, K SR Sastry, D V Rao. American Institute of Physics, Woodbury, NY 1992; 403–412, (http://www.aapm.org/pubs/books/PROC_8.pdf)
  • Hofer K G. Biophysical aspects of Auger processes – a review. Acta Oncologica 1996; 35: 789–796
  • Hofer K G. Biophysical aspects of Auger processes. Acta Oncologica 2000; 39: 651–657
  • Hofer K G, Hughes W L. Radiotoxicity of intranuclear tritium, iodine-125 and iodine-131. Radiation Research 1971; 47: 94–109
  • Horgan J. The end of science: Facing the limits of knowledge in the twilight of the scientific age. Addison-Wesley, Reading, MA 1996
  • Hosain F, Hosain P, Spencer R P. Testicular imaging with thallium-201 and comparison with other radionuclides. Journal of Nuclear Medicine 1978; 19: 720–720
  • Hou D Y, Hoch H, Johnston G S, Tsou K C, Jones A E, Farkas R J, Miller E E, Larson S M. A new In-111 bleomycin complex for combined radiotherapy and chemotherapy. Journal of Surgical Oncology 1985; 29: 91–98
  • Howell R W. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 1992; 19: 1371–1383
  • Howell R W, Kassis A I, Adelstein S J, Rao D V, Wright H A, Hamm R N, Turner J E, Sastry K SR. Radiotoxicity of 195mPt labeled trans-platinum(II) in mammalian cells. Radiation Research 1994; 140: 55–62
  • Howell R W, Narra V R, Rao D V, Sastry K SR. Radiobiological effects of intracellular polonium-210 alpha emissions: A comparison with Auger-emitters. Radiation Protection Dosimetry 1990; 31: 325–328
  • R W Howell, Narra, V R, Sastry, K SR, Rao, D V. Biophysical aspects of Auger processes, American Institute of Physics (http://www.aapm.org/pubs/books/PROC_8.pdf). New York 1992
  • Howell R W, Sastry K SR, Hill H Z, Rao D V. Cis-platinum-193m: Its microdosimetry and potential for chemo-Auger combination therapy of cancer. A T Schlafke-Stelson, E E Watson. National Technical Information Service, Springfield, VA 1986; 493–513
  • Hu M, Chen P, Wang J, Scollard D A, Vallis K A, Reilly R M. (123)I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1). European Journal of Nuclear Medicine and Molecular Imaging 2007; 34: 368–377
  • Ickenstein L M, Edwards K, Sjoberg S, Carlsson J, Gedda L. A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy. Nuclear Medicine and Biology 2006; 33: 773–783
  • Jaaskela-Saari H A, Grenman R, Ramsay H A, Tarkkanen J, Paavonen T, Kairemo K J. Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice. Cancer Biotherapy and Radiopharmaceuticals 2005; 20: 426–435
  • Kassis A I. The amazing world of Auger electrons. International Journal of Radiation Biology 2004; 80: 789–803
  • Kassis A I, Adelstein S J, Haydock C, Sastry K SR. Radiotoxicity of Se-75 and S-35: Theory and application to a cellular model. Radiation Research 1980; 84: 407–425
  • Kassis A I, Guptill W E, Taube R A, Adelstein S J. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine. Journal Nuclear Biology and Medicine 1991; 35: 167–173
  • Kassis A I, Harapanhalli R S, Adelstein S J. Comparison of strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125. Radiation Research 1999; 151: 167–176
  • Kato H S, Furukawa M, Kawai M, Taniguchi M, Kawai T, Hatsui T, Kosugi N. Electronic structure of bases in DNA duplexes characterized by resonant photoemission spectroscopy near the Fermi level. Physical Review Letters 2004; 93, 086403
  • Kawai J. Radiative Auger effect and extended X-ray emission fine structure (EXEFS). Analytical Sciences 2005; 21: 733–735
  • Kawai J, Ohta M, Konishi T. Chemical effects in high-resolution nickel Kα X-ray fluorescence spectra. Analytical Sciences 2005; 21: 865–868
  • Kienberger R, Goulielmakis E, Uiberacker M, Baltuska A, Yakovlev V, Bammer F, Scrinzi A, Westerwalbesloh T, Kleineberg U, Heinzmann U, Drescher M, Krausz F. Atomic transient recorder. Nature 2004; 427: 817–821
  • Kishikawa H, Wang K, Adelstein S J, Kassis A I. Inhibitory and stimulatory bystander effects are differentially induced by Iodine-125 and Iodine-123. Radiation Research 2006; 165: 688–694
  • Knapp F F, Mirzadeh H, Beets A L, Du M. Production of therapeutic isotopes in the ORNL High Flux Isotope Reactor (HIFR) for applications in nuclear medicine, oncology, and interventional cardiology. Journal of Radiochemical and Nuclear Chemistry 2005; 263: 503–509
  • Konijnenberg M, Melis M, Valkema R, Krenning E, de Jong M. Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy. Journal of Nuclear Medicine 2007; 48: 134–142
  • Korde A, Pandey U, Banerjee S, Dev Sarma H, Mukherjee A, Venkatesh M. Preparation and biological studies of 125I-DOTA-TATE. Applied Radiation and Isotopes 2007; 65: 687–690
  • Kou J, Mori T, Kumar S V, Haruyama Y, Kubozono Y, Mitsuke K. Double photoionization of C(60) and C(70) in the valence region. Journal of Chemical Physics 2004; 120: 6005–6009
  • Kriehuber R, Kadenbach K, Schultz F, Weiss D G. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the Auger electron emitter (99m)Tc. International Journal of Radiation Biology 2004a; 80: 875–880
  • Kriehuber R, Riedling M, Simko M, Weiss D G. Cytotoxicity, genotoxicity and intracellular distribution of the Auger electron emitter 65Zn in two human cell lines. Radiation and Environmental Biophysics 2004b; 43: 15–22
  • Kugeler O, Prumper G, Hentges R, Viefhaus J, Rolles D, Becker U, Marburger S, Hergenhahn U. Intramolecular electron scattering and electron transfer following autoionization in dissociating molecules. Physical Review Letters 2004; 93, 033002
  • Kullberg E B, Stenerlow B, Ghirmai S, Lundqvist H, Malmstrom P U, Orlova A, Tolmachev V, Gedda L. An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assay. International Journal of Oncology 2005; 27: 1355–1360
  • Kümmerle E A, Pomplun E. A computer-generated supercoiled model of the pUC19 plasmid. European Biophysics Journal 2005; 34: 13–18
  • Laughton C A, Grindon C, Girard P, Nikjoo H. The mysteries of telomere structure and recognition: could radioprobing help?. International Journal of Radiation Biology 2004; 80: 805–811
  • Li W B. Calculation of DNA strand breakage by neutralisation effect after 125I decays in a synthetic oligodeoxynucleotide using charge transfer theory. Radiation Protection Dosimetry 2006; 122: 89–94
  • Li W B, Friedland W, Jacob P, Panyutin I G, Paretzke H G. Simulation of 125I decay in a synthetic oligodeoxynucleotide with normal and distorted geometry and the role of radiation and non-radiation actions. Radiation and Environmental Biophysics 2004; 43: 23–33
  • Limouris G S, Dimitropoulos N, Kontogeorgakos D, Papanikolos G, Koutoulidis V, Hatzioannou A, Mourikis D, Lyra M, Dimitriou P, Stravaka A, Vlahos L. Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings. Cancer Biotherapy and Radiopharmaceuticals 2005; 20: 215–217
  • Lobachevsky P N, Karagiannis T C, Martin R F. Plasmid DNA breakage by decay of DNA-associated Auger electron emitters: Approaches to analysis of experimental data. Radiation Research 2004; 162: 84–95
  • Lobachevsky P N, Martin R F. DNA breakage by decay of Auger electron emitters: experiments with 123I-iodoHoechst 33258 and plasmid DNA. Radiation Research 2005; 164: 766–773
  • Malonda A G, Carles A G, Garcia G. Mean values of the LMM Auger transition in a KLM model. Applied Radiation and Isotopes 2006; 64: 1485–1491
  • McQuade P, Knight L C, Welch M J. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting α v β3 integrins in tumor angiogenesis. Bioconjugate Chemistry 2004; 15: 988–996
  • Meitner L. Das β-strahlenspektrum von UX1 und seine deutung. Zeitschrift für Physik 1923; 17: 54–66
  • Melero Garcia E, Kivimaki A, Pettersson L G, Alvarez Ruiz J, Coreno M, de Simone M, Richter R, Prince K C. Fluorescence emission of excited hydrogen atoms after core excitation of water vapor. Physical Review Letters 2006; 96, 063003
  • Michel R B, Andrews P M, Castillo M E, Mattes M J. In vitro cytotoxicity of carcinoma cells with 111In-labeled antibodies to HER-2. Molecular Cancer Therapy 2005a; 4: 927–937
  • Michel R B, Andrews P M, Rosario A V, Goldenberg D M, Mattes M J. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo. Nuclear Medicine and Biology 2005b; 32: 269–278
  • Michel R B, Castillo M E, Andrews P M, Mattes M J. In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons. Clinical Cancer Research 2004; 10: 5957–5966
  • Michel R B, Rosario A V, Andrews P M, Goldenberg D M, Mattes M J. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons. Clinical Cancer Research 2005c; 11: 777–786
  • Narra V R, Sastry K SR, Goddu S M, Howell R W, Strand S E, Rao D V. Relative biological effectiveness of 99mTc radiopharmaceuticals. Medical Physics 1994; 21: 1921–1926
  • Neti P VSV, Howell R W. Log normally distributed cellular uptake of radioactivity: Implications for biological responses to radiopharmaceuticals. Journal of Nuclear Medicine 2006; 47: 1049–1058
  • Nettleton J S, Lawson R S, Prescott M C, Morris I D. Uptake, localization, and dosimetry of 111In and 201Tl in human testes. Journal of Nuclear Medicine 2004; 45: 138–146
  • Nikjoo H, Girard P, Charlton D E, Hofer K G, Laughton C A. Auger electrons – a nanoprobe for structural, molecular and cellular processes. Radiation Protection Dosimetry 2006; 122: 72–79
  • Obata A, Kasamatsu S, Lewis J S, Furukawa T, Takamatsu S, Toyohara J, Asai T, Welch M J, Adams S G, Saji H, Yonekura Y, Fujibayashi Y. Basic characterization of 64Cu-ATSM as a radiotherapy agent. Nuclear Medicine and Biology 2005; 32: 21–28
  • Ohrwall G, Fink R F, Tchaplyguine M, Ojamae L, Lundwall M, Marinho R R, Naves de Brito A, Sorensen S L, Gisselbrecht M, Feifel R, Rander T, Lindblad A, Schulz J, Saethre L J, Martensson N, Svensson S, Bjorneholm O. The electronic structure of free water clusters probed by Auger electron spectroscopy. Journal of Chemical Physics 2005; 123, 054310
  • Panyutin I G, Neumann R D. Sequence-specific DNA double-strand breaks induced by triplex forming 125I labeled oligonucleotides. Nucleic Acids Research 1994; 22: 4979–4982
  • Panyutin I G, Neumann R D. The potential for gene-targeted radiation therapy of cancers. Trends in Biotechnology 2005; 23: 492–496
  • Panyutin I G, Winters T A, Feinendegen L E, Neumann R D. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. Quarterly Journal of Nuclear Medicine 2000; 44: 256–267
  • Panyutin I V, Sedelnikova O A, Bonner W M, Panyutin I G, Neumann R D. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei. Annals of the New York Academy of Sciences 2005; 1058: 140–150
  • Perillo-Adamer F, Delaloye A B, Genton C S, Schaffland A O, Dupertuis Y M, Buchegger F. Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine. European Journal of Nuclear Medicine and Molecular Imaging 2006; 33: 613–620
  • Pernpointner M, Knecht S. The influence of relativistic effects on the ionization spectra of the alkali iodides. Chemical Physics Letters 2005; 410: 423–429
  • Pernpointner M, Knecht S, Cederbaum L S. Ionization spectra and electronic decay in small iodide clusters: fully relativistic results. Journal of Chemical Physics 2006; 125: 34309
  • Peudon A, Edel S, Terrissol M. Molecular basic data calculation for radiation transport in chromatin. Radiation Protection Dosimetry 2006; 122: 128–135
  • Pomplun E, Booz J, Charlton D E. A Monte Carlo simulation of Auger cascades. Radiation Research 1987; 111: 533–552
  • Pomplun E, Sutmann G. Is coulomb explosion a damaging mechanism for 125IUdR. International Journal of Radiation Biology 2004; 80: 855–860
  • Pomplun E, Terrissol M, Kummerle E. Estimation of a radiation weighting factor for 99mTc. Radiation Protection Dosimetry 2006; 122: 80–81
  • Pospisil P, Wang K, Al Aowad A F, Iyer L K, Adelstein S J, Kassis A I. Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors. Cancer Research 2007; 67: 2197–2205
  • Rao D V, Govelitz G F, Sastry K SR. Radiotoxicity of thallium-201 in mouse testes: Inadequacy of conventional dosimetry. Journal of Nuclear Medicine 1983; 24: 145–153
  • Rao D V, Narra V R, Govelitz G F, Lanka V K, Howell R W, Sastry K SR. In vivo effects of 5.3 MeV alpha particles from Po-210 in mouse testes: Comparison with internal Auger emitters. Radiation Protection Dosimetry 1990; 31: 329–332
  • Rao D V, Sastry K SR, Grimmond H E, Howell R W, Govelitz G F, Lanka V K, Mylavarapu V B. Cytotoxicity of some indium radiopharmaceuticals in mouse testes. Journal of Nuclear Medicine 1988; 29: 375–384
  • Rao D V, Shepstone B, Wilkins H G, Howell R W. Testicular kinetics and dosimetry of Tl-201 in humans. Journal of Nuclear Medicine 1995; 36: 607–609
  • Reilly R M, Chen P, Wang J, Scollard D, Cameron R, Vallis K A. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: An Auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. Journal of Nuclear Medicine 2006; 47: 1023–1031
  • Reilly R M, Scollard D A, Wang J, Mondal H, Chen P, Henderson L A, Bowen B M, Vallis K A. A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications. Journal of Nuclear Medicine 2004; 45: 701–708
  • Reske S N, Deisenhofer S, Glatting G, Zlatopolskiy B D, Morgenroth A, Vogg A T, Buck A K, Friesen C. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in Doxorubicin-, β-, or γ-radiation-resistant cell lines. Journal of Nuclear Medicine 2007; 48: 1000–1007
  • Rousseau J, Boudou C, Esteve F, Elleaume H. Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy. International Journal of Radiation Oncology Biology Physics 2007; 68: 943–951
  • Sastry K SR. Biological effects of the Auger emitter 125I: A review. Report No. 1 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 1992; 19: 1361–1370
  • Sastry K SR, Rao D V. Dosimetry of low energy electrons. D V Rao, R Chandra, M Graham. American Institute of Physics, New York 1984; 169–208
  • Schaffland A O, Delaloye A B, Kosinski M, Dupertuis Y M, Buchegger F. The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy. Nuclear Medicine Communications 2004; 25: 461–468
  • Schipper M L, Riese C G, Seitz S, Weber A, Behe M, Schurrat T, Schramm N, Keil B, Alfke H, Behr T M. Efficacy of (99m)Tc pertechnetate and (131)I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. European Journal of Nuclear Medicine Molecular Imaging 2007; 34: 638–650
  • Sech C L, Takakura K, Saint-Marc C, Frohlich H, Charlier M, Usami N, Kobayashi K. Strand break induction by photoabsorption in DNA-bound molecules. Radiation Research 2000; 153: 454–458
  • Semnani E S, Wang K, Adelstein S J, Kassis A I. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: Radiopharmaceutical formulation affects targeting. Journal of Nuclear Medicine 2005; 46: 800–806
  • Sokolov M V, Smirnova N A, Camerini-Otero R D, Neumann R D, Panyutin I G. Microarray analysis of differentially expressed genes after exposure of normal human fibroblasts to ionizing radiation from an external source and from DNA-incorporated iodine-125 radionuclide. Gene 2006; 382: 47–56
  • Stokkel M P, Verkooijen R B, Bouwsma H, Smit J W. Six month follow-up after 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: A pilot study. Nuclear Medicine Communications 2004; 25: 683–690
  • Takahashi O, Odelius M, Nordlund D, Nilsson A, Bluhm H, Pettersson L G. Auger decay calculations with core-hole excited-state molecular-dynamics simulations of water. Journal of Chemical Physics 2006; 124: 64307
  • Tanis J A, Landers A L, Pole D J, Alnaser A S, Hossain S, Kirchner T. Evidence for Pauli exchange leading to excited-state enhancement in electron transfer. Physical Review Letters 2004; 92: 133201
  • Uiberacker M, Uphues T, Schultze M, Verhoef A J, Yakovlev V, Kling M F, Rauschenberger J, Kabachnik N M, Schroder H, Lezius M, Kompa K L, Muller H G, Vrakking M J, Hendel S, Kleineberg U, Heinzmann U, Drescher M, Krausz F. Attosecond real-time observation of electron tunnelling in atoms. Nature 2007; 446: 627–632
  • Urashima T, Nagasawa H, Wang K, Adelstein S J, Little J B, Kassis A I. Induction of apoptosis in human tumor cells after exposure to Auger electrons: Comparison with gamma-ray exposure. Nuclear Medicine and Biology 2006; 33: 1055–1063
  • Usami N, Furusawa Y, Kobayashi K, Frohlich H, Lacombe S, Le Sech C. Fast He2+ ion irradiation of DNA loaded with platinum-containing molecules. International Journal of Radiation Biology 2005; 81: 515–522
  • Uusijärvi H, Bernhardt P, Ericsson T, Forssell-Aronsson E. Dosimetric characterization of radionuclides for systemic tumor therapy: Influence of particle range, photon emission, and subcellular distribution. Medical Physics 2006; 33: 3260–3269
  • Van Houten B, Woshner V, Santos J H. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amsterdam) 2006; 5: 145–152
  • VanBrocklin H F, Hanrahan S M, Enas J D, Nandanan E, O'Neil J P. Mitochondrial avid radioprobes. Preparation and evaluation of 7' (Z)-[125I]iodorotenone and 7' (Z)-[125I]iodorotenol. Nuclear Medicine and Biology 2007; 34: 109–116
  • Viefhaus J, Cvejanovic S, Langer B, Lischke T, Prumper G, Rolles D, Golovin A V, Grum-Grzhimailo A N, Kabachnik N M, Becker U. Energy and angular distributions of electrons emitted by direct double auger decay. Physical Review Letters 2004; 92, 083001
  • Villani C, Tarantelli F. Double ionization of fluorinated benzenes: Hole localization and delocalization effects. Journal of Chemical Physics 2004; 120: 1775–1791
  • Wang K, Kirichian A M, Aowad A F, Adelstein S J, Kassis A I. Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative. Bioconjugate Chemistry 2007; 18: 754–764
  • Watanabe N, Sawai H, Ogihara-Umeda I, Tanada S, Kim E E, Yonekura Y, Sasaki Y. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides. Journal of Nuclear Medicine 2006; 47: 1670–1677
  • Wright H A, Hamm R N, Turner J E, Howell R W, Rao D V, Sastry K SR. Calculations of physical and chemical reactions with DNA in aqueous solution from Auger cascades. Radiation Protection Dosimetry 1990; 31: 59–62
  • Yakushev E A, Kovalik A, Filosofov D V, Korolev N A, Lebedev N A, Lubashevski A V, Rosch F, Novgorodov A F. An experimental comparison of the K- and L-Auger electron spectra generated in the decays of 140Nd and 111In. Applied Radiation and Isotopes 2005; 62: 451–456
  • Yasui L S, Chen K, Wang K, Jones T P, Caldwell J, Guse D, Kassis A I. Using Hoechst 33342 to target radioactivity to the cell nucleus. Radiation Research 2007; 167: 167–175
  • Yasui L S, Hofer K G. Role of mitochondrial DNA in cell death induced by I-125 decay. International Journal of Radiation Biology 1986; 49: 601–610

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.